SEI Investments’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,276
| Closed | -$235K | – | 2817 |
|
|
2025
Q1 | $235K | Sell |
17,276
-6,771
| -28% | -$92.1K | ﹤0.01% | 2428 |
|
|
2024
Q4 | $490K | Sell |
24,047
-2,229
| -8% | -$45.4K | ﹤0.01% | 2196 |
|
|
2024
Q3 | $765K | Buy |
26,276
+3,606
| +16% | +$105K | ﹤0.01% | 2038 |
|
|
2024
Q2 | $526K | Buy |
22,670
+10,598
| +88% | +$246K | ﹤0.01% | 2139 |
|
|
2024
Q1 | $248K | Buy |
12,072
+211
| +2% | +$4.33K | ﹤0.01% | 2373 |
|
|
2023
Q4 | $255K | Sell |
11,861
-399
| -3% | -$8.56K | ﹤0.01% | 2372 |
|
|
2023
Q3 | $253K | Sell |
12,260
-4,261
| -26% | -$87.9K | ﹤0.01% | 2362 |
|
|
2023
Q2 | $488K | Buy |
16,521
+153
| +0.9% | +$4.52K | ﹤0.01% | 2137 |
|
|
2023
Q1 | $377K | Buy |
16,368
+3,667
| +29% | +$84.5K | ﹤0.01% | 2246 |
|
|
2022
Q4 | $353K | Sell |
12,701
-3,317
| -21% | -$92.2K | ﹤0.01% | 2147 |
|
|
2022
Q3 | $492K | Buy |
16,018
+5,660
| +55% | +$174K | ﹤0.01% | 2093 |
|
|
2022
Q2 | $305K | Sell |
10,358
-160
| -2% | -$4.71K | ﹤0.01% | 2315 |
|
|
2022
Q1 | $328K | Sell |
10,518
-834
| -7% | -$26K | ﹤0.01% | 2270 |
|
|
2021
Q4 | $498K | Sell |
11,352
-433
| -4% | -$19K | ﹤0.01% | 2103 |
|
|
2021
Q3 | $588K | Buy |
11,785
+3,174
| +37% | +$158K | ﹤0.01% | 2003 |
|
|
2021
Q2 | $675K | Sell |
8,611
-11,119
| -56% | -$872K | ﹤0.01% | 1953 |
|
|
2021
Q1 | $1.43M | Buy |
19,730
+1,864
| +10% | +$135K | ﹤0.01% | 1606 |
|
|
2020
Q4 | $1.5M | Sell |
17,866
-490
| -3% | -$41.1K | ﹤0.01% | 1518 |
|
|
2020
Q3 | $658K | Buy |
+18,356
| New | +$658K | ﹤0.01% | 1790 |
|